Printable View
Biz bu isi bilmiyoruz...Alıntı:
Originally Posted by 666
120 endekste kardayiz yap hedgeni ac sortlarini ister 50 k ya insin borsa ...
Yapamadik olmadi.
Full giriyoruz sigorta icin para ayirmiyoruz.
Corona muhabbeti çıktığı zaman endeks sortla hisse longlari sigorta yapmak lazimdi, kacirdik.
Bir yerden dönecek endeksler, ama oyle böyle değil.Alıntı:
Originally Posted by Yıldıztozu
Bu saçma dususunde cok sacma cikisi olacak.
O grafiklerde üst dirençler de piyasa yapıcı sattiysa aşağı kırıyor, satis yediyse yukari kiriyor. Her halinde o kazaniyor[emoji16]Alıntı:
Originally Posted by Yıldıztozu
2008 de arada sert yukarı yaptığı günler de oluyordu en karamsar günlerde bile.Alıntı:
Originally Posted by osisa
Bunda frensiz iniyor.
Bu iş çok uzamadan toparlansa ben de aynı fikirdeyim ama uzarsa etkileri derinlesirse şirketleri fazla etkileyeceğinden yeni degerlemelerle çıkışın kısa ve kolay olacağından emin değilim.
Yatırım tavsiyesi değildir.
Human Testing Begins Earlier Than Expected For U.S. Coronavirus Vaccine
Vaccine expected to take anywhere from a year to 18 months to develop
WASHINGTON—The first human testing of Moderna Inc.’s experimental vaccine against the novel coronavirus has begun, the National Institutes of Health said on Monday.
Bu yüzden hareketsiz kalmam daha iyi.Alıntı:
Originally Posted by osisa
Etrafta zenciler varken duşta yere düşen sabunu almak için eğilmem.O beli bir daha asla dogrultamamak da var 😆
Experimental COVID-19 Vaccine Test Begins as U.S. Volunteer Receives First Shot
(SEATTLE) — U.S. researchers gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday — leading off a worldwide hunt for protection even as the pandemic surges.
With a careful jab in a healthy volunteer’s arm, scientists at the Kaiser Permanente Washington Research Institute in Seattle begin an anxiously awaited first-stage study of a potential COVID-19 vaccine developed in record time after the new virus exploded from China and fanned across the globe.
“We’re team coronavirus now,” Kaiser Permanente study leader Dr. Lisa Jackson said on the eve of the experiment. “Everyone wants to do what they can in this emergency.”
The Associated Press observed as the study’s first participant, an operations manager at a small tech company, received the injection inside an exam room. Several others were next in line for a test that will ultimately give 45 volunteers two doses, a month apart.
“We all feel so helpless. This is an amazing opportunity for me to do something,” said Jennifer Haller, 43, of Seattle. She’s the mother of two teenagers and “they think it’s cool” that she’s taking part in the study.
Monday’s milestone marked just the beginning of a series of studies in people needed to prove whether the shots are safe and could work. Even if the research goes well, a vaccine wouldn’t be available for widespread use for 12 to 18 months, said Dr. Anthony Fauci of the U.S. National Institutes of Health. That’s still important if the virus becomes a long-term threat.
Asi baslamis insanlar uzerinde test edilmeye. Ama 12-18 ay diyor piyasaya surulmesi.